XBRANE BIOPHARMA AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2405 SEK | -3.80% |
|
+19.06% | -97.60% |
| 05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 | |
| 05-16 | Xbrane Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XBRANE BIOPHARMA AB | Other Biotechnology & Medical Research | -3.80% | +19.06% | -97.60% | -99.66% | -99.36% | 35.61M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- XBRANE Stock
- Charts Xbrane Biopharma AB
- Comparison Chart
